Prognostic value of C-reactive protein and neopterin in autologous bone marrow cells transplantation

Kardiologiya

Volumn 46, Issue 1, 2006, Pages 19-26

  Shumakov, V I ^a   Shevtchenko, O P ^a   Kazakov, E N ^a   Orlova, O V ^a   Gureev, S V ^a   Makarova, L V ^a  

^a State Research Institute for Restoration   (Russian Federation)

Author keywords

C reactive protein; Cell transplantation; Heart failure; Neopterin

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; NEOPTERIN;

ADULT; AGED; ARTICLE; AUTOTRANSPLANTATION; BLOOD; BONE MARROW TRANSPLANTATION; COMPARATIVE STUDY; CONGESTIVE HEART FAILURE; DISEASE COURSE; FEMALE; FOLLOW UP; HEART STROKE VOLUME; HOSPITALIZATION; HUMAN; MALE; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PROGNOSIS;

ADULT; AGED; BIOLOGICAL MARKERS; BONE MARROW TRANSPLANTATION; C-REACTIVE PROTEIN; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE, CONGESTIVE; HUMANS; MALE; MIDDLE AGED; NEOPTERIN; PROGNOSIS; SEVERITY OF ILLNESS INDEX; STROKE VOLUME; TRANSPLANTATION, AUTOLOGOUS;

EID: 33645210851     PISSN: 00229040     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Hamono K., Nishida M., Hirata K et al. Local implantation of autologous bone marrow cells for therapeutic angiogenesis in patients with ischemic heart disease: clinical trial and preliminary results. Jap Circulat J 2001;65:845-847.
2. Orlic D., Hill J.M., Arai A.E. Stem cell for myocardial regeneration. Circulat Rev 2002;91:1092-1102.
3. Scorsin M., Hagege A.A., Vilquin J. T. et al. Comparison of the effects of cardiomyocytes and skeletal myoblasts transplantation on post-infarct left ventricular function. J Thorac Cardiovasc Surg 2000;119:1169-1175.
4. Hutcheson K.A., Atkins B.Z., Hueman M.T. et al. Comparison of benefits on myocardial performance of cellular cardiomyoplasty with skeletal myoblasts and fibroblasts. Cell Transplant 2000;9:359-368.
5. Badorff C., Brandes R.P., Popp R. et al. Transdifferentiation of blood-derived human adult endothelial progenitor cells into functionally active cardiomyocytes. Circulation 2003;106:1024-1032.
6. Menasche P., Hagege A.A., Vilquin J.T. et al. Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction. J Am Coll Cardiol 2003;41:1078-1083.
7. Assmus B., Schachinger V., Teupe C. et al. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction. Circulation 2002;106:3009-3017.
8. Strauer B.E., Brehm M., Zeus T. et al. Repair of infracted myocardium by autologus intracoronary mononuclear bone marrow cell transplantation in humans. Circulation 2002;106:1913-1918.
9. Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med 1999;104:115-126.
10. Tracy R.P., Lemaitre R.N., Psaty B.M. et al. Relationship study of C-reactive protein to risk of cardiovascular disease in the elderly: results from the Cardiovascular Health Study and the Rural Health Promotion Project. Atheroscler Tromb Vasc Biol 1997;17:1121-1127.
11. Buffon A., Liuzzo G., Biasucci L.M. et al. Peripocedural serum levels of C-reactive protein predict early complications and late restenosis after coronary angioplasty. J Am Coll Cardiol 1999;34:1512-1521.
12. Koening W., Sund M., Frohlich M. et al. C-reactive protein a sensitive marker of inflammation, predict future risk of coronary heart disease in initially healthy middle-aged men. Results from MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Ausburg Cohort study, 1984 to 1992. Circulation 1999;99:237-242.
13. Fuchs D., Gruber A., Murr C. et al. Use of neopterin for the monitoring of cell-mediated immune response in vivo. In: The immune consequences of trauma, shock and sepsis. Mechanisms and therapeutic approaches. Eds. Faist E., Bauer A.E., Schildberg F.W. Lengerich: Pabst Science Publishers 1996;2:1:144-150.
14. Strandberg T.E., Vanhanen H., Tikkanen M.J. Effect of statins on C-reactive protein in patients with coronary artery disease. Lancet 1999;353:118-119.